Citation Impact
Citing Papers
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
Distinguished Guest Lecture: The Persistence and Change of Institutions in the Americas
2008 StandoutNobel
Coxsackievirus Myocarditis: Interplay between Virus and Host in the Pathogenesis of Heart Disease
2006
Cancer immunotherapies targeting the PD-1 signaling pathway
2017 StandoutNobel
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
2010 StandoutNobel
Hemodynamic improvement and removal of autoantibodies against β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy
2003
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
PD-1/PD-L pathway and autoimmunity
2005
Non-specific immunoadsorption in patients with dilated cardiomyopathy: Mechanisms and clinical effects
2006
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
2004
Nonlinear elasticity in biological gels
2005 StandoutNature
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
β1-adrenoceptor antibodies induce positive inotropic response in isolated cardiomyocytes
2001
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 StandoutNobel
Update on Myocarditis
2012 Standout
PD-1 and PD-1 ligands: from discovery to clinical application
2007
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
2005 StandoutNobel
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study
2006
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Myocarditis
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Building Inclusive Markets in Rural Bangladesh: How Intermediaries Work Institutional Voids
2012 Standout
Myocarditis
2006 Standout
The mechanical properties of actin gels. Elastic modulus and filament motions.
1994
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
The Study of Critical Junctures: Theory, Narrative, and Counterfactuals in Historical Institutionalism
2007 Standout
The silence of the archives: business history, post-colonialism and archival ethnography
2013 Standout
Roepke Lecture in Economic Geography—Rethinking Regional Path Dependence: Beyond Lock‐in to Evolution
2009 Standout
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
2014 Standout
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
2010 StandoutNobel
Institutional Emergence in an Era of Globalization: The Rise of Transnational Private Regulation of Labor and Environmental Conditions
2007 Standout
Persistence of Power, Elites, and Institutions
2008 StandoutNobel
Liquid-Liquid Phase Separation in Biology
2014 Standout
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption
2002
How Institutions Evolve
2004 Standout
Varieties of business history: Subject and methods for the twenty-first century
2011
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
The Hybridization of Vocational Training and Higher Education in Austria, Germany, and Switzerland
2013 Standout
Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution
2001
Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
2004
Persistence of Power, Elites, and Institutions
2006 StandoutNobel
Taking ideas and discourse seriously: explaining change through discursive institutionalism as the fourth ‘new institutionalism’
2010 Standout
Advances in the Understanding of Myocarditis
2001
The Persistence and Change of Institutions in the Americas
2008 StandoutNobel
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
The promise and limits of private power: promoting labor standards in a global economy
2014 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
2020 Standout
Works of Manfred Pohl being referenced
Die Eisenbahn in Deutschland : von den Anfängen bis zur Gegenwart
1999
Unternehmen im Nationalsozialismus
1998
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy
2000
Viscoelastic behaviour of human blood and polyacrylamide model fluids for heart valve testing
1993
Zwischen Weihrauch und Wissenschaft? Zum Standort der modernen Unternehmensgeschichte
1999